Saltar al contenido
Merck

89170

Sigma-Aldrich

Thorium oxide

≥99.0%

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

Fórmula lineal:
ThO2
Número de CAS:
Peso molecular:
264.04
Número CE:
Número MDL:
Código UNSPSC:
12352300
ID de la sustancia en PubChem:

Análisis

≥99.0%

idoneidad de la reacción

reagent type: catalyst
core: thorium

Extensión del etiquetado

7.15 kBq/g specific activity

cadena SMILES

O=[Th]=O

InChI

1S/2O.Th

Clave InChI

ZCUFMDLYAMJYST-UHFFFAOYSA-N

¿Está buscando productos similares? Visita Guía de comparación de productos

Advertencia

Regulations require a license for the sale of radioactive substances in Switzerland. Swiss customers are kindly requested when ordering, to include their license number, issued by the Swiss Public Health Authorities.

Otras notas

Sales restrictions may apply
Regulations require a license for the sale of radioactive substances in Switzerland. Swiss customers are kindly requested when ordering, to include their license number, issued by the Swiss Public Health Authorities.

Pictogramas

Health hazardSkull and crossbones

Palabra de señalización

Danger

Frases de peligro

Clasificaciones de peligro

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Carc. 1B - STOT RE 2

Código de clase de almacenamiento

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

Clase de riesgo para el agua (WGK)

WGK 3

Punto de inflamabilidad (°F)

Not applicable

Punto de inflamabilidad (°C)

Not applicable


Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

[Carcinogenic chemicals and risk of hematopoietic neoplasms].
Masanobu Kobayashi
Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 2, 39-42 (2012-11-09)
Yoichiro Yamamoto et al.
Health physics, 99(3), 388-393 (2010-08-12)
Irradiation from internally deposited radionuclides induces malignant tumors. Ingested radionuclides accumulate in specific organs, which are irradiated over a lifelong period. Our aim is to elucidate why the development of malignant tumors requires long-term internal exposure, on the order of
Rakesh K Behera et al.
Journal of physics. Condensed matter : an Institute of Physics journal, 24(21), 215405-215405 (2012-05-12)
Thorium dioxide (ThO(2)) is of great interest to energy research as thorium-based nuclear fuel offers the promise of increased proliferation resistance, longer fuel cycles, higher burn-up and improved wasteform characteristics in the generation of nuclear power. However, understanding of ThO(2)
Yoichiro Yamamoto et al.
Cancer science, 101(2), 336-340 (2009-11-18)
Exposure to internally deposited radionuclides is known to induce malignant tumors of various histological types. Thorotrast, a colloidal suspension of radioactive Thorium dioxide ((232)ThO(2)) that emits alpha-particles, was used as a radiographic contrast during World War II. Thorotrast is known
G van Kaick et al.
Der Radiologe, 51(12), 1052-1057 (2011-11-18)
The medical management and counseling of persons at high risk due to exposure to chemicals or radiation or due to personal disposition, present an additional challenge for physicians and especially radiologists involved. This article is based on own experiences with

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico